{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.526.3.402","meta":{"versionId":"25","lastUpdated":"2022-03-02T18:05:36.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.402","version":"20170908","name":"Influenza Vaccination","status":"active","date":"2022-03-03T18:46:01-05:00","publisher":"NCQA PHEMUR","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1761"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.199"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1351"]}]},"expansion":{"identifier":"urn:uuid:346f44fc-6621-468d-87f8-25e9dfba68da","timestamp":"2022-06-10T08:49:11-04:00","total":30,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"86198006","display":"Administration of vaccine product containing only Influenza virus antigen (procedure)"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90630","display":"Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90653","display":"Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90654","display":"Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90655","display":"Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90656","display":"Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90657","display":"Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90658","display":"Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90661","display":"Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90662","display":"Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90666","display":"Influenza virus vaccine (IIV), pandemic formulation, split virus, preservative free, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90667","display":"Influenza virus vaccine (IIV), pandemic formulation, split virus, adjuvanted, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90668","display":"Influenza virus vaccine (IIV), pandemic formulation, split virus, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90673","display":"Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90674","display":"Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90682","display":"Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90685","display":"Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90686","display":"Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90687","display":"Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90688","display":"Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90689","display":"Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90694","display":"Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90756","display":"Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G0008","display":"Administration of influenza virus vaccine"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"Q2034","display":"Influenza virus vaccine, split virus, for intramuscular use (agriflu)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"Q2035","display":"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"Q2036","display":"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"Q2037","display":"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"Q2038","display":"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"Q2039","display":"Influenza virus vaccine, not otherwise specified"}]}}